Ophthalmic formulation
AssigneeWestern Sydney University
InventorsThomas Millar, Burkhardt Schuett
Life of this patent
Estimating the term…
Abstract
Disclosed herein is an ophthalmic formulation comprising a compound of formula (I) wherein R1 is a linear or branched C9-C33 alkyl or a linear or branched C9-C33 alkenyl with 1 to 4 double bonds; R2 is a linear or branched C9-C19 alkyl or a linear or branched C9-C19 alkenyl with 1 to 4 double bonds; and an ophthalmologically acceptable carrier.
Claims24
An ophthalmic formulation comprising a compound of formula (I):
- wherein
- R1 is a linear or branched C9-C33 alkyl or a linear or branched C9-C33 alkenyl with 1 to 4 double bonds;
- R2 is a linear or branched C9-C19 alkyl or a linear or branched C9-C19 alkenyl with 1 to 4 double bonds;
- and an ophthalmologically acceptable carrier.
A compound of the following formula:
A compound of the following formula:
A compound of the following formula:
A compound of the following formula:
A compound of the following formula:
A compound of the following formula:
A compound of the following formula:
Dependencies are inferred from the claim text.